{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:50:36Z","timestamp":1787071836321,"version":"build-2736575974"},"reference-count":57,"publisher":"Walter de Gruyter GmbH","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glomerular disease is a common issue in nephrology, where prompt diagnosis and appropriate treatment are crucial to halting disease progression and preventing the development of chronic kidney disease or end-stage kidney disease. The initial approach and differential diagnosis remain essential clinical skills for ensuring timely investigation and management. In an era of advanced molecular diagnostics in histopathology and biologic therapies, there is a notable gap in the literature regarding a general introduction to the overarching concepts of glomerular disease. This article aims to serve as a guide for medical students and internists, offering an overview of the approach to glomerular disease, including differential diagnoses, the clinical features of nephritis and nephrotic syndrome, and common presentations that aid in diagnosis, such as foamy urine, hematuria, and proteinuria.<\/jats:p>","DOI":"10.2478\/abm-2025-0036","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:02:56Z","timestamp":1771509776000},"page":"374-382","source":"Crossref","is-referenced-by-count":0,"title":["A beginner\u2019s guide to the clinical approach and key concepts of glomerular disease: a mini review"],"prefix":"10.2478","volume":"19","author":[{"given":"Suwasin","family":"Udomkarnjananun","sequence":"first","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society , Bangkok , Thailand"},{"name":"Excellence Center for Organ Transplantation (ECOT), King Chulalongkorn Memorial Hospital, The Thai Red Cross Society , Bangkok , Thailand"},{"name":"Center of Excellence in Renal Immunology and Renal Transplantation, Faculty of Medicine, Chulalongkorn University , Bangkok , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talerngsak","family":"Kanjanabuch","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society , Bangkok , Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis A.","family":"Hesselink","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Transplantation, Erasmus MC, University Medical Center , Rotterdam , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"2026081815590587161_j_abm-2025-0036_ref_001","doi-asserted-by":"crossref","unstructured":"Madaio MP, Harrington JT. The diagnosis of glomerular diseases: acute glomerulonephritis and the nephrotic syndrome. Arch Intern Med. 2001; 161:25\u201334.","DOI":"10.1001\/archinte.161.1.25"},{"key":"2026081815590587161_j_abm-2025-0036_ref_002","doi-asserted-by":"crossref","unstructured":"Hebert LA, Parikh S, Prosek J, Nadasdy T, Rovin BH. Differential diagnosis of glomerular disease: a systematic and inclusive approach. Am J Nephrol. 2013; 38:253\u201366.","DOI":"10.1159\/000354390"},{"key":"2026081815590587161_j_abm-2025-0036_ref_003","doi-asserted-by":"crossref","unstructured":"Ahn W, Bomback AS. Approach to diagnosis and management of primary glomerular diseases due to podocytopathies in adults: core curriculum 2020. Am J Kidney Dis. 2020; 75:955\u201364.","DOI":"10.1053\/j.ajkd.2019.12.019"},{"key":"2026081815590587161_j_abm-2025-0036_ref_004","doi-asserted-by":"crossref","unstructured":"Sethi S, De Vriese AS, Fervenza FC. Acute glomerulonephritis. Lancet. 2022; 399:1646\u201363.","DOI":"10.1016\/S0140-6736(22)00461-5"},{"key":"2026081815590587161_j_abm-2025-0036_ref_005","doi-asserted-by":"crossref","unstructured":"Kronbichler A, Bajema I, Geetha D, S\u00e4emann M. Novel aspects in the pathophysiology and diagnosis of glomerular diseases. Ann Rheum Dis. 2023; 82:585\u201393.","DOI":"10.1136\/ard-2022-222495"},{"key":"2026081815590587161_j_abm-2025-0036_ref_006","doi-asserted-by":"crossref","unstructured":"Windpessl M, Odler B, Bajema IM, Geetha D, S\u00e4emann M, Lee JM, et al. Glomerular diseases across lifespan: key differences in diagnostic and therapeutic approaches. Semin Nephrol. 2023; 43:151435. doi: 10.1016\/j.semnephrol.2023.151435","DOI":"10.1016\/j.semnephrol.2023.151435"},{"key":"2026081815590587161_j_abm-2025-0036_ref_007","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021; 100:S1\u2013S276."},{"key":"2026081815590587161_j_abm-2025-0036_ref_008","unstructured":"Rondon-Berrios H. New insights into the pathophysiology of oedema in nephrotic syndrome. Nefrologia. 2011; 31:148\u201354."},{"key":"2026081815590587161_j_abm-2025-0036_ref_009","doi-asserted-by":"crossref","unstructured":"Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012; 82:635\u201342.","DOI":"10.1038\/ki.2012.180"},{"key":"2026081815590587161_j_abm-2025-0036_ref_010","doi-asserted-by":"crossref","unstructured":"Kang KK, Choi JR, Song JY, Han SW, Park SH, Yoo WS, et al. Clinical significance of subjective foamy urine. Chonnam Med J. 2012; 48:164\u20138.","DOI":"10.4068\/cmj.2012.48.3.164"},{"key":"2026081815590587161_j_abm-2025-0036_ref_011","doi-asserted-by":"crossref","unstructured":"Khitan ZJ, Glassock RJ. Foamy urine: is this a sign of kidney disease? Clin J Am Soc Nephrol. 2019; 14:1664\u20136.","DOI":"10.2215\/CJN.06840619"},{"key":"2026081815590587161_j_abm-2025-0036_ref_012","doi-asserted-by":"crossref","unstructured":"Sumida K, Nadkarni GN, Grams ME, Sang Y, Ballew SH, Coresh J, et al. Conversion of urine protein-creatinine ratio or urine dipstick protein to urine albumin-creatinine ratio for use in chronic kidney disease screening and prognosis: an individual participant-based meta-analysis. Ann Intern Med. 2020; 173:426\u201335.","DOI":"10.7326\/M20-0529"},{"key":"2026081815590587161_j_abm-2025-0036_ref_013","doi-asserted-by":"crossref","unstructured":"Hundemer GL, Imsirovic H, Visram A, McCurdy A, Knoll G, Biyani M, et al. The association between the urine protein-to-albumin gap and the diagnosis of multiple myeloma: a population-based retrospective cohort study. Am J Kidney Dis. 2023; 81:732\u20134.","DOI":"10.1053\/j.ajkd.2022.11.008"},{"key":"2026081815590587161_j_abm-2025-0036_ref_014","doi-asserted-by":"crossref","unstructured":"Saha MK, Massicotte-Azarniouch D, Reynolds ML, Mottl AK, Falk RJ, Jennette JC, et al. Glomerular hematuria and the utility of urine microscopy: a review. Am J Kidney Dis. 2022; 80:383\u201392.","DOI":"10.1053\/j.ajkd.2022.02.022"},{"key":"2026081815590587161_j_abm-2025-0036_ref_015","doi-asserted-by":"crossref","unstructured":"Schuetz E, Schaefer RM, Heidbreder E, Heidland A. Effect of diuresis on urinary erythrocyte morphology in glomerulonephritis. Klin Wochenschr. 1985; 63:575\u20137.","DOI":"10.1007\/BF01733007"},{"key":"2026081815590587161_j_abm-2025-0036_ref_016","doi-asserted-by":"crossref","unstructured":"Rath B, Turner C, Hartley B, Chantler C. What makes red cells dysmorphic in glomerular haematuria? Pediatr Nephrol. 1992; 6:424\u20137.","DOI":"10.1007\/BF00874000"},{"key":"2026081815590587161_j_abm-2025-0036_ref_017","doi-asserted-by":"crossref","unstructured":"Daza JL, De Rosa M, De Rosa G. Dysmorphic red blood cell formation. Cleve Clin J Med. 2018; 85:12\u20133.","DOI":"10.3949\/ccjm.85a.17029"},{"key":"2026081815590587161_j_abm-2025-0036_ref_018","doi-asserted-by":"crossref","unstructured":"Zaman Z, Proesmans W. Dysmorphic erythrocytes and G1 cells as markers of glomerular hematuria. Pediatr Nephrol. 2000; 14:980\u20134.","DOI":"10.1007\/s004670050057"},{"key":"2026081815590587161_j_abm-2025-0036_ref_019","doi-asserted-by":"crossref","unstructured":"K\u00f6hler H, Wandel E, Brunck B. Acanthocyturia \u2013 a characteristic marker for glomerular bleeding. Kidney Int. 1991; 40:115\u201320.","DOI":"10.1038\/ki.1991.188"},{"key":"2026081815590587161_j_abm-2025-0036_ref_020","doi-asserted-by":"crossref","unstructured":"Heine GH, Sester U, Girndt M, K\u00f6hler H. Acanthocytes in the urine: useful tool to differentiate diabetic nephropathy from glomerulonephritis? Diabetes Care. 2004; 27:190\u20134.","DOI":"10.2337\/diacare.27.1.190"},{"key":"2026081815590587161_j_abm-2025-0036_ref_021","doi-asserted-by":"crossref","unstructured":"Barros Silva GE, Costa RS, Ravinal RC. Saraiva e Silva J, Dantas M, Coimbra TM. Evaluation of erythrocyte dysmorphism by light microscopy with lowering of the condenser lens: a simple and efficient method. Nephrology (Carlton). 2010; 15:171\u20137.","DOI":"10.1111\/j.1440-1797.2009.01197.x"},{"key":"2026081815590587161_j_abm-2025-0036_ref_022","doi-asserted-by":"crossref","unstructured":"Hamadah AM, Gharaibeh K, Mara KC, Thompson KA, Lieske JC, Said S, et al. Urinalysis for the diagnosis of glomerulonephritis: role of dysmorphic red blood cells. Nephrol Dial Transplant. 2018; 33:1397\u2013403.","DOI":"10.1093\/ndt\/gfx274"},{"key":"2026081815590587161_j_abm-2025-0036_ref_023","doi-asserted-by":"crossref","unstructured":"Vaziri ND. Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int. 2016; 90:41\u201352.","DOI":"10.1016\/j.kint.2016.02.026"},{"key":"2026081815590587161_j_abm-2025-0036_ref_024","doi-asserted-by":"crossref","unstructured":"Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol. 2018; 14:57\u201370.","DOI":"10.1038\/nrneph.2017.155"},{"key":"2026081815590587161_j_abm-2025-0036_ref_025","doi-asserted-by":"crossref","unstructured":"Zhou Y, Zhang X, Chen L, Wu J, Dang H, Wei M, et al. Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats. Am J Physiol Renal Physiol. 2008; 295:F662\u201371.","DOI":"10.1152\/ajprenal.00046.2008"},{"key":"2026081815590587161_j_abm-2025-0036_ref_026","doi-asserted-by":"crossref","unstructured":"Haas ME, Levenson AE, Sun X, Liao WH, Rutkowski JM, de Ferranti SD, et al. The role of proprotein convertase subtilisin\/kexin type 9 in nephrotic syndrome-associated hypercholesterolemia. Circulation. 2016; 134:61\u201372.","DOI":"10.1161\/CIRCULATIONAHA.115.020912"},{"key":"2026081815590587161_j_abm-2025-0036_ref_027","doi-asserted-by":"crossref","unstructured":"Gherardi E, Rota E, Calandra S, Genova R, Tamborino A. Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome. Eur J Clin Invest. 1977; 7:563\u201370.","DOI":"10.1111\/j.1365-2362.1977.tb01652.x"},{"key":"2026081815590587161_j_abm-2025-0036_ref_028","doi-asserted-by":"crossref","unstructured":"O\u2019Shaughnessy MM, Hogan SL, Thompson BD, Coppo R, Fogo AB, Jennette JC. Glomerular disease frequencies by race, sex and region: results from the International kidney biopsy survey. Nephrol Dial Transplant. 2018; 33:661\u20139.","DOI":"10.1093\/ndt\/gfx189"},{"key":"2026081815590587161_j_abm-2025-0036_ref_029","doi-asserted-by":"crossref","unstructured":"Goto K, Imaizumi T, Hamada R, Ishikura K, Kosugi T, Narita I, et al. Renal pathology in adult and paediatric population of Japan: review of the Japan renal biopsy registry database from 2007 to 2017. J Nephrol. 2023; 36:2257\u201367.","DOI":"10.1007\/s40620-023-01687-9"},{"key":"2026081815590587161_j_abm-2025-0036_ref_030","doi-asserted-by":"crossref","unstructured":"Kanjanabuch T, Isaranuwatchai S, Nopsopon T, Thammathiwat T, Pooprasert T, Puapatanakul P, et al. Exploring hospital practice types and their impact on glomerular pathologic patterns: insights from the largest kidney biopsy cohort in Thailand. Nephrology (Carlton). 2023; 28(Suppl 1):24\u201334.","DOI":"10.1111\/nep.14202"},{"key":"2026081815590587161_j_abm-2025-0036_ref_031","doi-asserted-by":"crossref","unstructured":"Thurman JM. Complement in kidney disease: core curriculum 2015. Am J Kidney Dis. 2015; 65:156\u201368.","DOI":"10.1053\/j.ajkd.2014.06.035"},{"key":"2026081815590587161_j_abm-2025-0036_ref_032","doi-asserted-by":"crossref","unstructured":"Zipfel PF, Wiech T, Gr\u00f6ne HJ, Skerka C. Complement catalyzing glomerular diseases. Cell Tissue Res. 2021; 385:355\u201370.","DOI":"10.1007\/s00441-021-03485-w"},{"key":"2026081815590587161_j_abm-2025-0036_ref_033","unstructured":"Johnson RJ, Feehally J, Floege J Jr. Comprehensive clinical nephrology. Philadelphia, PA: Elsevier\/Saunders; 2015. Available from: https:\/\/www.clinicalkey.com\/dura\/browse\/bookChapter\/3-s2.0-C20120000294"},{"key":"2026081815590587161_j_abm-2025-0036_ref_034","doi-asserted-by":"crossref","unstructured":"Zand L, Kattah A, Fervenza FC, Smith RJ, Nasr SH, Zhang Y, et al. C3 glomerulonephritis associated with monoclonal gammopathy: a case series. Am J Kidney Dis. 2013; 62:506\u201314.","DOI":"10.1053\/j.ajkd.2013.02.370"},{"key":"2026081815590587161_j_abm-2025-0036_ref_035","doi-asserted-by":"crossref","unstructured":"Ravindran A, Fervenza FC, Smith RJH, Sethi S. C3 glomerulopathy associated with monoclonal Ig is a distinct subtype. Kidney Int. 2018; 94:178\u201386.","DOI":"10.1016\/j.kint.2018.01.037"},{"key":"2026081815590587161_j_abm-2025-0036_ref_036","doi-asserted-by":"crossref","unstructured":"Smith RJH, Appel GB, Blom AM, Cook HT, D\u2019Agati VD, Fakhouri F, et al. C3 glomerulopathy \u2013 understanding a rare complement driven renal disease. Nat Rev Nephrol. 2019; 15:129\u201343.","DOI":"10.1038\/s41581-018-0107-2"},{"key":"2026081815590587161_j_abm-2025-0036_ref_037","doi-asserted-by":"crossref","unstructured":"Medjeral-Thomas NR, Cook HT, Pickering MC. Complement activation in IgA nephropathy. Semin Immunopathol. 2021; 43:679\u201390.","DOI":"10.1007\/s00281-021-00882-9"},{"key":"2026081815590587161_j_abm-2025-0036_ref_038","doi-asserted-by":"crossref","unstructured":"Tringali E, Vetrano D, Tondolo F, Maritati F, Fabbrizio B, Pasquinelli G, et al. Role of serum complement C3 and C4 on kidney outcomes in IgA nephropathy. Sci Rep. 2024; 14:16224. doi: 10.1038\/s41598-024-65857-w","DOI":"10.1038\/s41598-024-65857-w"},{"key":"2026081815590587161_j_abm-2025-0036_ref_039","doi-asserted-by":"crossref","unstructured":"Russell MW, Mansa B. Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA. Scand J Immunol. 1989; 30:175\u201383.","DOI":"10.1111\/j.1365-3083.1989.tb01199.x"},{"key":"2026081815590587161_j_abm-2025-0036_ref_040","doi-asserted-by":"crossref","unstructured":"Maillard N, Wyatt RJ, Julian BA, Kiryluk K, Gharavi A, Fremeaux-Bacchi V, et al. Current understanding of the role of complement in IgA nephropathy. J Am Soc Nephrol. 2015; 26:1503\u201312.","DOI":"10.1681\/ASN.2014101000"},{"key":"2026081815590587161_j_abm-2025-0036_ref_041","doi-asserted-by":"crossref","unstructured":"Bao L, Cunningham PN, Quigg RJ. Complement in lupus nephritis: new perspectives. Kidney Dis (Basel). 2015; 1:91\u20139.","DOI":"10.1159\/000431278"},{"key":"2026081815590587161_j_abm-2025-0036_ref_042","doi-asserted-by":"crossref","unstructured":"Kharouf F, Li Q, Whittall Garcia LP, Jauhal A, Gladman DD, Touma Z. Short- and long-term outcomes of patients with pure membranous lupus nephritis compared with patients with proliferative disease. Rheumatology (Oxford). 2025; 64:1912\u201322.","DOI":"10.1093\/rheumatology\/keae436"},{"key":"2026081815590587161_j_abm-2025-0036_ref_043","doi-asserted-by":"crossref","unstructured":"Fraticelli P, Benfaremo D, Gabrielli A. Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med. 2021; 16:831\u201341.","DOI":"10.1007\/s11739-021-02688-x"},{"key":"2026081815590587161_j_abm-2025-0036_ref_044","doi-asserted-by":"crossref","unstructured":"Esson GA, Hussain AB, Meggitt SJ, Reynolds NJ, Sayer JA. Cutaneous manifestations of acute kidney injury. Clin Kidney J. 2022; 15:855\u201364.","DOI":"10.1093\/ckj\/sfab255"},{"key":"2026081815590587161_j_abm-2025-0036_ref_045","unstructured":"Poyan Mehr A, Jonasdottir A. GlomCon Pubs (accessed on 27 February 2025). Available from: https:\/\/pubs.glomcon.org\/measuring-outcomes-in-glomerular-diseases\/"},{"key":"2026081815590587161_j_abm-2025-0036_ref_046","doi-asserted-by":"crossref","unstructured":"Kashtan CE, Ding J, Garosi G, Heidet L, Massella L, Nakanishi K, et al. Alport Syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int. 2018; 93:1045\u201351.","DOI":"10.1016\/j.kint.2017.12.018"},{"key":"2026081815590587161_j_abm-2025-0036_ref_047","doi-asserted-by":"crossref","unstructured":"Leisring J, Brodsky SV, Parikh SV. Clinical evaluation and management of thrombotic microangiopathy. Arthritis Rheumatol. 2024; 76:153\u201365.","DOI":"10.1002\/art.42681"},{"key":"2026081815590587161_j_abm-2025-0036_ref_048","doi-asserted-by":"crossref","unstructured":"Udomkarnjananun S, Townamchai N, Virojanawat M, Avihingsanon Y, Praditpornsilpa K. An unusual manifestation of calcineurin inhibitor-induced pain syndrome in kidney transplantation: a case report and literature review. Am J Case Rep. 2018; 19:442\u20136.","DOI":"10.12659\/AJCR.908886"},{"key":"2026081815590587161_j_abm-2025-0036_ref_049","doi-asserted-by":"crossref","unstructured":"Moghaddas Sani H, Zununi Vahed S, Ardalan M. Preeclampsia: a close look at renal dysfunction. Biomed Pharmacother. 2019; 109:408\u201316.","DOI":"10.1016\/j.biopha.2018.10.082"},{"key":"2026081815590587161_j_abm-2025-0036_ref_050","doi-asserted-by":"crossref","unstructured":"D\u2019Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004; 43:368\u201382.","DOI":"10.1053\/j.ajkd.2003.10.024"},{"key":"2026081815590587161_j_abm-2025-0036_ref_051","doi-asserted-by":"crossref","unstructured":"Deegens JK, Steenbergen EJ, Borm GF, Wetzels JF. Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population \u2013 epidemiology and outcome. Nephrol Dial Transplant. 2008; 23:186\u201392.","DOI":"10.1093\/ndt\/gfm523"},{"key":"2026081815590587161_j_abm-2025-0036_ref_052","doi-asserted-by":"crossref","unstructured":"Umanath K, Lewis JB. Update on diabetic nephropathy: core curriculum 2018. Am J Kidney Dis. 2018; 71:884\u201395.","DOI":"10.1053\/j.ajkd.2017.10.026"},{"key":"2026081815590587161_j_abm-2025-0036_ref_053","doi-asserted-by":"crossref","unstructured":"Samsu N. Diabetic nephropathy: challenges in pathogenesis, diagnosis, and treatment. Biomed Res Int. 2021; 2021:1497449. doi: 10.1155\/2021\/1497449","DOI":"10.1155\/2021\/1497449"},{"key":"2026081815590587161_j_abm-2025-0036_ref_054","doi-asserted-by":"crossref","unstructured":"Shi S, Ni L, Gao L, Wu X. Comparison of nonalbuminuric and albuminuric diabetic kidney disease among patients with type 2 diabetes: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022; 13:871272. doi: 10.3389\/fendo.2022.871272","DOI":"10.3389\/fendo.2022.871272"},{"key":"2026081815590587161_j_abm-2025-0036_ref_055","doi-asserted-by":"crossref","unstructured":"Scilletta S, Di Marco M, Miano N, Filippello A, Di Mauro S, Scamporrino A, et al. Update on diabetic kidney disease (DKD): focus on non-albuminuric DKD and cardiovascular risk. Biomolecules. 2023; 13:752. doi: 10.3390\/biom13050752","DOI":"10.3390\/biom13050752"},{"key":"2026081815590587161_j_abm-2025-0036_ref_056","doi-asserted-by":"crossref","unstructured":"Di Vincenzo A, Bettini S, Russo L, Mazzocut S, Mauer M, Fioretto P. Renal structure in type 2 diabetes: facts and misconceptions. J Nephrol. 2020; 33:901\u20137.","DOI":"10.1007\/s40620-020-00797-y"},{"key":"2026081815590587161_j_abm-2025-0036_ref_057","doi-asserted-by":"crossref","unstructured":"Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020; 22(Suppl 1):3\u201315.","DOI":"10.1111\/dom.14007"}],"container-title":["Asian Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/abm-2025-0036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:59:38Z","timestamp":1787068778000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/abm-2025-0036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12,31]]},"published-print":{"date-parts":[[2025,12,1]]}},"alternative-id":["10.2478\/abm-2025-0036"],"URL":"https:\/\/doi.org\/10.2478\/abm-2025-0036","relation":{},"ISSN":["1875-855X"],"issn-type":[{"value":"1875-855X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}